Chirurgische Klinik München-Bogenhausen
Denninger Str. 44
81679 München

Weitere Kontakte  »

 

Urologie ist
unsere Leidenschaft

Publikationen

Prof. Dr. med. Hans-Martin Fritsche

Buchkapitel

“Intracavernous, Intraurethral and Topical Therapies in the Era of Oral Pharmacotherapy for Erectile Dysfunction – Salvaging first line Therapies”; in: “Oral Pharmacotherapy of Erectile Dysfunction”; Herausgeber: Broderick, Mayo Clinic, Jacksonville, Florida Humana Press, New Jersey, USA (2005)

“Extracorporeal shock wave lithotripsy in the year 2012”; in: “Clinical Management of Urolithiasis”; Herausgeber: Knoll, Pearle; Springer Verlag (2012)

„Epidemiology and Risk Factors for Upper Urinary Urothelial Cancers“; in: „Upper Tract Urothelial Carcinoma“; Herausgeber: Shariat, Xylinas; Springer Verlag (2014)

Publikationen

1: May M, Schönthaler M, Gilfrich C, Wolff I, Peter J, Miernik A, Fritsche HM, Burger M, Schostak M, Lebentrau S; BUSTER-Arbeitsgruppe. [Interrater reliability and clinical impact of the Post-Ureteroscopic Lesion Scale (PULS) grading system for ureteral lesions after ureteroscopy : Results of the German prospective multicenter BUSTER project]. Urologe A. 2018 Jan 10. doi: 10.1007/s00120-017-0565-3. [Epub ahead of print] German. PubMed PMID: 29322235.

2: Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA. The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma. Urol Oncol. 2018 Jan;36(1):10.e7-10.e14. doi: 10.1016/j.urolonc.2017.09.012. Epub 2017 Oct 18. PubMed PMID: 29055518.

3: Vetterlein MW, Gild P, Kluth LA, Seisen T, Gierth M, Fritsche HM, Burger M, Protzel C, Hakenberg OW, von Landenberg N, Roghmann F, Noldus J, Nuhn P, Pycha A, Rink M, Chun FK, May M, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int. 2018 Jan;121(1):101-110. doi: 10.1111/bju.14012. Epub 2017 Oct 11. PubMed PMID: 28905486.

4: Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P. The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol. 2017 Dec;35(12):671.e17-671.e23. doi: 10.1016/j.urolonc.2017.08.007. Epub 2017 Sep 8. PubMed PMID: 28889922.

5: Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 Study Group. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Eur Urol Focus. 2016 Jul 18. pii: S2405-4569(16)30099-2. doi: 10.1016/j.euf.2016.07.001. [Epub ahead of print] PubMed PMID: 28753775.

6: May M, Spachmann PJ, Lebentrau S, Schumacher H, Gilfrich C, Fritsche HM, Vetterlein M, Brookman-May S, Schostak M, Wagenlehner FM, Burger M, Novotny A, Obermaier R. [Do General Surgeons Feel Adequately Prepared for the Complex Questions Associated with the Handling of Multi-Resistant Pathogens? - Results of the MR2 Survey]. Zentralbl Chir. 2017 Jun;142(3):297-305. doi: 10.1055/s-0042-120546. Epub 2017 Jun 22. German. PubMed PMID: 28641352.

7: May M, Vetterlein MW, Wagenlehner FM, Brookman-May SD, Gilfrich C, Fritsche HM, Spachmann PJ, Burger M, Schostak M, Lebentrau S; MR2-Studiengruppe. [What is the perception of the 10-point plan of the German Federal Ministry of Health against multidrug-resistant pathogens and measures of antibiotic stewardship? : An interdisciplinary analysis among German clinicians and development of a decision tool for urologists]. Urologe A. 2017 Oct;56(10):1302-1310. doi: 10.1007/s00120-017-0425-1. German. PubMed PMID: 28593351.

8: Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study group. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort. Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817. doi: 10.1016/j.clgc.2017.04.021. Epub 2017 Apr 26. PubMed PMID: 28550955.

9: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner FM, Burger M, May M; MR2 study group. Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol. 2017 Aug;49(8):1311-1318. doi: 10.1007/s11255-017-1603-1. Epub 2017 Apr 21. PubMed PMID: 28432607.

10: Breyer J, Otto W, Lausenmeyer EM, Denzinger S, Schwientek AK, Ochs L, Mayr R, Gierth M, Bründl J, Burger M, Evert M, Fritsche HM, Eichelberg C. [Clinical and pathological prognostic factors for the long-term survival of patients with pT1 renal cell carcinoma]. Aktuelle Urol. 2017 May;48(3):230-237. doi: 10.1055/s-0043-101725. Epub 2017 Apr 19. German. PubMed PMID: 28423432.

11: May M, Protzel C, Vetterlein MW, Gierth M, Noldus J, Karl A, Grimm T, Wullich B, Grimm MO, Nuhn P, Bastian PJ, Roigas J, Hadaschik B, Gilfrich C, Burger M, Fisch M, Brookman-May S, Aziz A, Hakenberg OW; PROMETRICS 2011 Research Group. Is there evidence for a close connection between side of intravesical tumor location and ipsilateral lymphatic spread in lymph node-positive bladder cancer patients at radical cystectomy? Results of the PROMETRICS 2011 database. Int Urol Nephrol. 2017 Feb;49(2):247-254. doi: 10.1007/s11255-016-1469-7. Epub 2016 Nov 28. PubMed PMID: 27896578.

12: Sayedahmed K, Rosenhammer B, Spachmann PJ, Burger M, Aragona M, Kaftan BT, Olianas R, Fritsche HM. Bicentric prospective evaluation of corporoplasty with porcine small intestinal submucosa (SIS) in patients with severe Peyronie's disease. World J Urol. 2017 Jul;35(7):1119-1124. doi: 10.1007/s00345-016-1973-5. Epub 2016 Nov 18. PubMed PMID: 27864619.

13: Soria F, Shariat SF, Lerner SP, Fritsche HM, Rink M, Kassouf W, Spiess PE, Lotan Y, Ye D, Fernández MI, Kikuchi E, Chade DC, Babjuk M, Grollman AP, Thalmann GN. Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC). World J Urol. 2017 Mar;35(3):379-387. doi: 10.1007/s00345-016-1928-x. Epub 2016 Sep 7. Review. PubMed PMID: 27604375.

14: Salem J, Borgmann H, Bultitude M, Fritsche HM, Haferkamp A, Heidenreich A, Miernik A, Neisius A, Knoll T, Thomas C, Tsaur I. Online Discussion on #KidneyStones: A Longitudinal Assessment of Activity, Users and Content. PLoS One. 2016 Aug 18;11(8):e0160863. doi: 10.1371/journal.pone.0160863. eCollection 2016. PubMed PMID: 27537406; PubMed Central PMCID: PMC4990296.

15: Gakis G, Efstathiou JA, Daneshmand S, Keegan KA, Clayman RH, Hrbacek J, Ali-El-Dein B, Zaid HB, Schubert T, Mischinger J, Todenhöfer T, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Morgan TM. Oncological Outcomes of Patients with Concomitant Bladder and Urethral Carcinoma. Urol Int. 2016;97(2):134-41. doi: 10.1159/000448335. Epub 2016 Jul 28. PubMed PMID: 27462702.

16: May M, Gilfrich C, Spachmann P, Maurer O, Dombrowski MK, Fritsche HM, Wöhr M, Brookman-May S, Karl T, Schostak M, Burger M, Lebentrau S. [What do prostate cancer patients know about smoking? : Results of a bicentric questionnaire study (KRAUT study)]. Urologe A. 2016 Aug;55(8):1078-85. doi: 10.1007/s00120-016-0165-7. German. PubMed PMID: 27364819.

17: Abt D, Dötzer K, Honek P, Müller K, Engeler DS, Burger M, Schmid HP, Knoll T, Sanguedolce F, Joshi HB, Fritsche HM. The German linguistic validation of the Ureteral Stent Symptoms Questionnaire (USSQ). World J Urol. 2017 Mar;35(3):443-447. doi: 10.1007/s00345-016-1875-6. Epub 2016 Jun 23. PubMed PMID: 27339622.

18: May M, Fritsche HM, Vetterlein MW, Bastian PJ, Gierth M, Nuhn P, Aziz A, Fisch M, Stief CG, Hohenfellner M, Wirth MP, Novotny V, Hakenberg OW, Noldus J, Gilfrich C, Bolenz C, Burger M, Brookman-May SD; PROMETRICS 2011 Research Group. Impact of photodynamic diagnosis-assisted transurethral resection of bladder tumors on the prognostic outcome after radical cystectomy: results from PROMETRICS 2011. World J Urol. 2017 Feb;35(2):245-250. doi: 10.1007/s00345-016-1877-4. Epub 2016 Jun 14. PubMed PMID: 27300339.

19: Vallo S, Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM, Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A, Fisch M, Aziz A. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder. Urol Oncol. 2016 Oct;34(10):432.e1-8. doi: 10.1016/j.urolonc.2016.05.008. Epub 2016 Jun 6. PubMed PMID: 27283218.

20: Gakis G, Rink M, Fritsche HM, Graefen M, Schubert T, Hassan F, Chun FK, Brummeisl W, Fisch M, Burger M, Stenzl A, Renninger M. Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer. Urol Int. 2016;97(1):42-8. doi: 10.1159/000443239. Epub 2016 Jan 9. PubMed PMID: 26744841.

21: Schneidewind L, Kranz J, Boehm K, Spachmann P, Siegel F, Huck N, Fritsche HM. [Antibiotic stewardship (ABS). Definition, contents, necessity and practice on examples of current clinical-urological controversies]. Urologe A. 2016 Apr;55(4):489-93. doi: 10.1007/s00120-015-0012-2. Review. German. PubMed PMID: 26646716.

22: Seisen T, Nison L, Remzi M, Klatte T, Mathieu R, Lucca I, Bozzini G, Capitanio U, Novara G, Cussenot O, Compérat E, Renard-Penna R, Peyronnet B, Merseburger AS, Fritsche HM, Hora M, Shariat SF, Colin P, Rouprêt M. Oncologic Outcomes of Kidney Sparing Surgery versus Radical Nephroureterectomy for the Elective Treatment of Clinically Organ Confined Upper Tract Urothelial Carcinoma of the Distal Ureter. J Urol. 2016 May;195(5):1354-61. doi: 10.1016/j.juro.2015.11.036. Epub 2015 Nov 21. PubMed PMID: 26612196.

23: Rink M, Soave A, Dahlem R, Aziz A, Al-Sayed F, Peine S, Engel O, Kluth LA, Stenzl A, Burger M, Shariat SF, Fisch M, Fritsche HM, Gakis G. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Clin Genitourin Cancer. 2016 Feb;14(1):96-104. doi: 10.1016/j.clgc.2015.10.003. Epub 2015 Oct 20. PubMed PMID: 26506908.

24: Neisius A, Thomas C, Roos FC, Hampel C, Fritsche HM, Bach T, Thüroff JW, Knoll T. [Asymptomatic kidney stones: active surveillance vs. treatment]. Aktuelle Urol. 2015 Sep;46(5):391-4. doi: 10.1055/s-0035-1559651. Epub 2015 Sep 17. Review. German. PubMed PMID: 26378390.

25: Ahmed A, Eckerl M, Bründl J, Peter J, Lebentrau S, Brookman-May S, Fritsche HM, Burger M, May M, Gilfrich C. Postoperative Leukocytosis After Robotic-Assisted Radical Prostatectomy Is Not Associated with Perioperative Outcome and Histopathological Findings. J Laparoendosc Adv Surg Tech A. 2015 Oct;25(10):808-13. doi: 10.1089/lap.2014.0578. Epub 2015 Aug 10. PubMed PMID: 26259047.

26: Wilhelm K, Fritsche HM, Netsch C; AG „Endourologie und Urolithiasis“ der GeSRU Academics. [Percutaneous Stone Treatment Today: Standard-, Mini-, Micro-, Ultramini-PCNL]. Aktuelle Urol. 2015 Jul;46(4):297-302. doi: 10.1055/s-0035-1555863. Epub 2015 Jul 30. Review. German. PubMed PMID: 26227130.

27: Schnabel MJ, Brummeisl W, Burger M, Rassweiler JJ, Knoll T, Neisius A, Chaussy CG, Fritsche HM. [Shock wave lithotripsy in Germany: Results of a nationwide survey]. Urologe A. 2015 Sep;54(9):1277-82. doi: 10.1007/s00120-015-3920-2. German. PubMed PMID: 26223953.

28: Kluth LA, Xylinas E, Rieken M, Kent M, Ikeda M, Matsumoto K, Hagiwara M, Kikuchi E, Bing MT, Gupta A, Sewell JM, Konety BR, Todenhöfer T, Schwentner C, Masson-Lecomte A, Vordos D, Roghmann F, Noldus J, Razmaria AA, Smith ND, Comploj E, Pycha A, Rink M, Baniel J, Mano R, Novara G, Aziz A, Fritsche HM, Brisuda A, Bivalacqua T, Gontero P, Boorjian SA, Vickers AJ, Shariat SF. Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. Eur Urol Focus. 2015 Aug;1(1):75-81. doi: 10.1016/j.euf.2014.10.003. Epub 2015 May 28. PubMed PMID: 28723361.

29: Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF. Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. Eur Urol. 2015 Jul;68(1):171. doi: 10.1016/j.eururo.2015.02.007. Epub 2015 Feb 18. PubMed PMID: 26088736.

30: Schneidewind L, Boehm K, Spachmann P, Siegel F, Huck N, Kranz J, Fritsche HM. [Research activities of the GeSRU Academics urological infections group. Projects that pave the way for the best group performance]. Urologe A. 2015 Jun;54(6):875-7. doi: 10.1007/s00120-015-3860-x. German. PubMed PMID: 25989876.

31: Gakis G, Morgan TM, Efstathiou JA, Keegan KA, Mischinger J, Todenhoefer T, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Daneshmand S. Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma. World J Urol. 2016 Jan;34(1):97-103. doi: 10.1007/s00345-015-1583-7. Epub 2015 May 17. PubMed PMID: 25981402.

32: Gakis G, Morgan TM, Daneshmand S, Keegan KA, Todenhöfer T, Mischinger J, Schubert T, Zaid HB, Hrbacek J, Ali-El-Dein B, Clayman RH, Galland S, Olugbade K, Rink M, Fritsche HM, Burger M, Chang SS, Babjuk M, Thalmann GN, Stenzl A, Efstathiou JA. Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma. Ann Oncol. 2015 Aug;26(8):1754-9. doi: 10.1093/annonc/mdv230. Epub 2015 May 12. PubMed PMID: 25969370.

33: Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M, May M; PROMETRICS 2011 Research Group. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World J Urol. 2015 Dec;33(12):1945-50. doi: 10.1007/s00345-015-1572-x. Epub 2015 May 7. PubMed PMID: 25947885.

34: Gierth M, Mayr R, Aziz A, Krieger S, Wullich B, Pycha A, Lodde M, Salvadori U, Bründl J, Fritsche HM, Hofstädter F, Pawlik MT, Otto W, May M, Burger M, Denzinger S. Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol. 2015 Oct;141(10):1819-26. doi: 10.1007/s00432-015-1957-7. Epub 2015 Apr 2. PubMed PMID: 25832016.

35: Novotny V, Froehner M, May M, Protzel C, Hergenröther K, Rink M, Chun FK, Fisch M, Roghmann F, Palisaar RJ, Noldus J, Gierth M, Fritsche HM, Burger M, Sikic D, Keck B, Wullich B, Nuhn P, Buchner A, Stief CG, Vallo S, Bartsch G, Haferkamp A, Bastian PJ, Hakenberg OW, Propping S, Aziz A. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2015 Nov;33(11):1753-61. doi: 10.1007/s00345-015-1502-y. Epub 2015 Feb 8. PubMed PMID: 25663359.

36: Aziz A, Shariat SF, Roghmann F, Brookman-May S, Stief CG, Rink M, Chun FK, Fisch M, Novotny V, Froehner M, Wirth MP, Schnabel MJ, Fritsche HM, Burger M, Pycha A, Brisuda A, Babjuk M, Vallo S, Haferkamp A, Roigas J, Noldus J, Stredele R, Volkmer B, Bastian PJ, Xylinas E, May M. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. BJU Int. 2016 Feb;117(2):272-9. doi: 10.1111/bju.12984. Epub 2015 May 24. PubMed PMID: 25381844.

37: Brummeisl W, Lausenmeyer E, Weber F, Bründl J, Fritsche HM, Burger M, Denzinger S. [Urethral condylomata acuminata]. Urologe A. 2015 Mar;54(3):378-84. doi: 10.1007/s00120-014-3619-9. Review. German. PubMed PMID: 25234950.

38: Breyer J, Denzinger S, Otto W, Bründl J, Gierth M, Fritsche HM, Rößler W, Wieland WF, Giedl C, Hofstädter F, Rubenwolf P, Burger M, Aziz A. Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients. Urol Int. 2014;93(3):311-9. doi: 10.1159/000360483. Epub 2014 Sep 4. PubMed PMID: 25196313.

39: Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, Gierth M, Pahernik Sh, Protzel C, Roigas J, Gördük M, Lusuardi L, May M, Trinh QD, Fisch M, Chun FK; PROMETRICS 2011 Research Group. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Ann Surg Oncol. 2015 Mar;22(3):1032-42. doi: 10.1245/s10434-014-4029-3. Epub 2014 Aug 28. PubMed PMID: 25164037.

40: Aziz A, Madersbacher S, Otto W, Mayr R, Comploj E, Pycha A, Denzinger S, Fritsche HM, Burger M, Gierth M. Comparative analysis of gender-related differences in symptoms and referral patterns prior to initial diagnosis of urothelial carcinoma of the bladder: a prospective cohort study. Urol Int. 2015;94(1):37-44. doi: 10.1159/000363334. Epub 2014 Aug 13. PubMed PMID: 25139297.

41: Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M. The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder. Urol Int. 2014;93(3):303-10. doi: 10.1159/000362421. Epub 2014 Aug 19. PubMed PMID: 25139069.

42: Aziz A, Rink M, Gakis G, Kluth LA, Dechet C, Miller F, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Fisch M, Burger M, Fritsche HM. Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Urol Int. 2014;93(3):352-60. doi: 10.1159/000362248. Epub 2014 Aug 19. PubMed PMID: 25138778.

43: Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy. Eur J Cancer. 2014 Oct;50(15):2583-91. doi: 10.1016/j.ejca.2014.07.003. Epub 2014 Jul 31. PubMed PMID: 25088206.

44: Nuhn P, Novara G, Seitz C, Gupta A, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Tritschler S, Martínez-Salamanca JI, Ficarra V, Karakiewicz PI, Mazzoleni G, Shariat SF, Bastian PJ. Prognostic value of prior history of urothelial carcinoma of the bladder in patients with upper urinary tract urothelial carcinoma: results from a retrospective multicenter study. World J Urol. 2015 Jul;33(7):1005-13. doi: 10.1007/s00345-014-1363-9. Epub 2014 Jul 22. PubMed PMID: 25048439.

45: Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A. Response to editorial comment from Dr Todenhöfer and Dr Schwentner to recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading. Int J Urol. 2014 Oct;21(10):974. doi: 10.1111/iju.12531. Epub 2014 Jun 19. PubMed PMID: 24947451.

46: Lodde M, Mian C, Mayr R, Comploj E, Trenti E, Melotti R, Campodonico F, Maffezzini M, Fritsche HM, Pycha A. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading. Int J Urol. 2014 Oct;21(10):968-72. doi: 10.1111/iju.12509. Epub 2014 Jun 19. PubMed PMID: 24947145.

47: Lucca I, Rouprêt M, Kluth L, Rink M, Tilki D, Fajkovic H, Kassouf W, Hofbauer SL, de Martino M, Karakiewicz PI, Briganti A, Trinh QD, Seitz C, Fritsche HM, Burger M, Lotan Y, Kramer G, Shariat SF, Klatte T. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients. BJU Int. 2015 May;115(5):722-7. doi: 10.1111/bju.12829. Epub 2015 Jan 26. PubMed PMID: 24905084.

48: May M, Brookman-May S, Burger M, Gilfrich C, Fritsche HM, Rink M, Chun F, Fisch M, Roghmann F, Noldus J, Mayr R, Pycha A, Novotny V, Wirth M, Vallo S, Haferkamp A, Roigas J, Brisuda A, Stredele R, Volkmer B, Dechet C, Schnabel M, Denzinger S, Stief CG, Bastian PJ, Aziz A. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy. Ann Surg Oncol. 2014 Nov;21(12):4034-40. doi: 10.1245/s10434-014-3827-y. Epub 2014 Jun 4. PubMed PMID: 24895114.

49: Aziz A, Fritsche HM, Gakis G, Kluth LA, Hassan Fa, Engel O, Dahlem R, Otto W, Gierth M, Denzinger S, Schwentner C, Stenzl A, Shariat SF, Fisch M, Burger M, Rink M. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy. Urol Oncol. 2014 Nov;32(8):1141-50. doi: 10.1016/j.urolonc.2014.04.008. Epub 2014 May 22. PubMed PMID: 24856977.

50: Schnabel MJ, Gierth M, Bründl J, Chaussy CG, Burger M, Fritsche HM. Antiplatelet and anticoagulative medication during shockwave lithotripsy. J Endourol. 2014 Sep;28(9):1034-9. doi: 10.1089/end.2014.0162. Epub 2014 Jul 15. Review. PubMed PMID: 24851726.

51: May M, Aziz A, Brookman-May S, Roghmann F, Noldus J, Rink M, Chun F, Fisch M, Novotny V, Wirth M, Mayr R, Pycha A, Brisuda A, Volkmer B, Stredele R, Dechet C, Vallo S, Haferkamp A, Schnabel M, Denzinger S, Roigas J, Stief CG, Gilfrich C, Bastian PJ, Engel JB, Burger M, Fritsche HM. Prognostic impact of infiltration of the vagina and/or uterus in women undergoing anterior pelvic exenteration for urothelial carcinoma of the bladder: results of a contemporary multicentre series. World J Urol. 2015 Mar;33(3):343-50. doi: 10.1007/s00345-014-1308-3. Epub 2014 May 10. PubMed PMID: 24817140.

52: Gierth M, Aziz A, Fritsche HM, Burger M, Otto W, Zeman F, Pawlik MT, Hansen E, May M, Denzinger S. The effect of intra- and postoperative allogenic blood transfusion on patients' survival undergoing radical cystectomy for urothelial carcinoma of the bladder. World J Urol. 2014 Dec;32(6):1447-53. doi: 10.1007/s00345-014-1257-x. Epub 2014 Feb 8. PubMed PMID: 24510120.

53: Fritsche HM. [Imaging - displaying ureteral stones: what is the best technique?]. Aktuelle Urol. 2014 Jan;45(1):9-12. doi: 10.1055/s-0034-1366935. Epub 2014 Feb 5. German. PubMed PMID: 24500950.

54: Messer JC, Shariat SF, Dinney CP, Novara G, Fradet Y, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Lotan Y, Skinner EC, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Wei C, Lerner SP, Curiel TJ, Kamat AM, Svatek RS. Female gender is associated with a worse survival after radical cystectomy for urothelial carcinoma of the bladder: a competing risk analysis. Urology. 2014 Apr;83(4):863-7. doi: 10.1016/j.urology.2013.10.060. Epub 2014 Jan 31. PubMed PMID: 24485993.

55: Schnabel MJ, Gierth M, Chaussy CG, Dötzer K, Burger M, Fritsche HM. Incidence and risk factors of renal hematoma: a prospective study of 1,300 SWL treatments. Urolithiasis. 2014 Jun;42(3):247-53. doi: 10.1007/s00240-014-0637-4. Epub 2014 Jan 14. PubMed PMID: 24419328.

56: Mayr R, Fritsche HM, Pycha A, Pycha A. Radical cystectomy and the implications of comorbidity. Expert Rev Anticancer Ther. 2014 Mar;14(3):289-95. doi: 10.1586/14737140.2014.868775. Epub 2014 Jan 8. Review. PubMed PMID: 24397794.

57: Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F; PROMETRICS 2011 research group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol. 2014 Jul;66(1):156-63. doi: 10.1016/j.eururo.2013.12.018. Epub 2013 Dec 27. PubMed PMID: 24388438.

58: May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer. Clin Genitourin Cancer. 2014 Aug;12(4):278-86. doi: 10.1016/j.clgc.2013.11.014. Epub 2013 Nov 13. PubMed PMID: 24331576.

59: Schoenthaler M, Buchholz N, Farin E, Ather H, Bach C, Bach T, Denstedt JD, Fritsche HM, Grasso M, Hakenberg OW, Herwig R, Knoll T, Kuehhas FE, Liatsikos E, Liske P, Marberger M, Osther PJ, Santos JM, Sarica K, Seitz C, Straub M, Traxer O, Trinchieri A, Turney B, Miernik A. The Post-Ureteroscopic Lesion Scale (PULS): a multicenter video-based evaluation of inter-rater reliability. World J Urol. 2014 Aug;32(4):1033-40. doi: 10.1007/s00345-013-1185-1. Epub 2013 Oct 18. PubMed PMID: 24135917.

60: Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Rouprêt M, Aziz A, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Walton T, Karakiewicz PI, Montorsi F, Zerbib M, Scherr DS, Shariat SF; UTUC Collaboration. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. Eur Urol. 2014 Mar;65(3):650-8. doi: 10.1016/j.eururo.2013.09.003. Epub 2013 Sep 19. PubMed PMID: 24070577.

61: Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Ikeda M, Matsumoto K, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gakis G, Novara G, Klatte T, Remzi M, Comploj E, Pycha A, Rouprêt M, Tagawa ST, Chun FK, Scherr DS, Vickers AJ, Shariat SF. Predictors of survival in patients with disease recurrence after radical nephroureterectomy. BJU Int. 2014 Jun;113(6):911-7. doi: 10.1111/bju.12369. PubMed PMID: 24053651.

62: Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2014 Feb;191(2):316-22. doi: 10.1016/j.juro.2013.09.010. Epub 2013 Sep 12. PubMed PMID: 24036235.

63: Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F. Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients. Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10. PubMed PMID: 23850551.

64: May M, Zigeuner R, Aziz A, Cindolo L, Gilfrich C, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Feciche B, Truss M, Hoschke B, Dalpiaz O, Stoltze A, Fenske F, Fritsche HM, Chromecki T, Lebentrau S, Figenshau RS, Madison K, Sánchez-Chapado M, Del Carmen Santiago Martin M, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief CG, Brookman-May S; Mitglieder des "CORONA projects"; Projektgruppe "Young Academic Urologists Renal Cancer Group" der European Association of Urology (EAU). [Postoperative prognosis of chromophobic renal cell carcinoma: comparative analysis of the multinational CORONA database]. Urologe A. 2014 Feb;53(2):228-35. doi: 10.1007/s00120-013-3237-y. German. PubMed PMID: 23836364.

65: Rud O, Horstmann M, Aziz A, Fritsche HM, Brookman-May S, Gilfrich C, Burger M, May M. Prospective evaluation of intra-observer variability of the hydronephrosis index in sonographic examination of 44 patients with acute renal colic. World J Urol. 2014 Jun;32(3):691-5. doi: 10.1007/s00345-013-1119-y. Epub 2013 Jun 23. PubMed PMID: 23793577.

66: Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy. Urol Int. 2013;91(1):97-102. doi: 10.1159/000350232. Epub 2013 Jun 6. PubMed PMID: 23751372.

67: Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation. World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5. PubMed PMID: 23736527.

68: Tilki D, Brausi M, Colombo R, Evans CP, Fradet Y, Fritsche HM, Lerner SP, Sagalowsky A, Shariat SF, Bochner BH. Lymphadenectomy for bladder cancer at the time of radical cystectomy. Eur Urol. 2013 Aug;64(2):266-76. doi: 10.1016/j.eururo.2013.04.036. Epub 2013 Apr 29. Review. PubMed PMID: 23648149.

69: May M, Aziz A, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Coman I, Truss M, Dalpiaz O, Hoschke B, Gilfrich C, Feciche B, Stoltze A, Fenske F, Fritsche HM, Figenshau RS, Madison K, Sánchez-Chapado M, Martin Mdel C, Salzano L, Lotrecchiano G, Joniau S, Waidelich R, Stief C, Brookman-May S; Members of the CORONA project the Young Academic Urologists Renal Cancer Group. Gender differences in clinicopathological features and survival in surgically treated patients with renal cell carcinoma: an analysis of the multicenter CORONA database. World J Urol. 2013 Oct;31(5):1073-80. doi: 10.1007/s00345-013-1071-x. Epub 2013 Apr 9. PubMed PMID: 23568445.

70: Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks. Eur J Surg Oncol. 2013 Apr;39(4):372-9. doi: 10.1016/j.ejso.2013.02.009. PubMed PMID: 23465180.

71: Hoschke B, Fenske S, Brookman-May S, Spivak I, Gilfrich C, Fritsche HM, Wolff I, May M. [Male circumcision is not associated with an increased prevalence of erectile dysfunction: results of the Cottbus 10,000-men survey]. Urologe A. 2013 Apr;52(4):562-9. doi: 10.1007/s00120-012-3112-2. German. PubMed PMID: 23361453.

72: Ganzer R, Fritsche HM, Brandtner A, Bründl J, Koch D, Wieland WF, Blana A. Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer. BJU Int. 2013 Aug;112(3):322-9. doi: 10.1111/j.1464-410X.2012.11715.x. Epub 2013 Jan 28. PubMed PMID: 23356910.

73: Brummeisl W, Fritsche HM, Huber E, Wieland WF, Ganzer R. A patient with fibroepithelial polyp of the ureter-a rare condition mimicking malignancy: a case report. Case Rep Urol. 2012;2012:901693. doi: 10.1155/2012/901693. Epub 2012 Dec 27. PubMed PMID: 23326750; PubMed Central PMCID: PMC3544255.

74: May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis. BJU Int. 2013 Aug;112(4):E383-90. doi: 10.1111/j.1464-410X.2012.11735.x. Epub 2013 Jan 10. PubMed PMID: 23305250.

75: Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001. PubMed PMID: 23217567.

76: M Al-Ali B, Gutschi T, Pummer K, Zigeuner R, Brookman-May S, Wieland WF, Fritsche HM, Aziz A. Body mass index has no impact on sperm quality but on reproductive hormones levels. Andrologia. 2014 Mar;46(2):106-11. doi: 10.1111/and.12051. Epub 2012 Nov 24. PubMed PMID: 23176091.

77: Xylinas E, Cha EK, Sun M, Rink M, Trinh QD, Novara G, Green DA, Pycha A, Fradet Y, Daneshmand S, Svatek RS, Fritsche HM, Kassouf W, Scherr DS, Faison T, Crivelli JJ, Tagawa ST, Zerbib M, Karakiewicz PI, Shariat SF. Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling. Br J Cancer. 2012 Nov 20;107(11):1826-32. doi: 10.1038/bjc.2012.464. PubMed PMID: 23169335; PubMed Central PMCID: PMC3504939.

78: Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A. Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy. World J Urol. 2012 Dec;30(6):841-6. doi: 10.1007/s00345-012-0975-1. Epub 2012 Nov 10. PubMed PMID: 23143733.

79: Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M. Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas. Urol Int. 2013;90(2):207-13. doi: 10.1159/000342639. Epub 2012 Oct 26. PubMed PMID: 23108244.

80: Rouprêt M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, Cussenot O, Martinez-Salamanca JI, Fritsche HM, Walton TJ, Wood CG, Bensalah K, Karakiewicz PI, Montorsi F, Margulis V, Shariat SF; French National Database on Upper Tract Tumors; Upper Tract Urothelial Carcinoma Collaboration. Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis. J Urol. 2013 May;189(5):1662-9. doi: 10.1016/j.juro.2012.10.057. Epub 2012 Oct 24. PubMed PMID: 23103802.

81: Xylinas E, Rink M, Novara G, Green DA, Clozel T, Fritsche HM, Guillonneau B, Lotan Y, Kassouf W, Tilki D, Babjuk M, Karakiewicz PI, Montorsi F, Abdennabi J, Trinh QD, Svatek RS, Scherr DS, Zerbib M, Shariat SF. Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy. Ann Surg Oncol. 2013 Mar;20(3):1027-34. doi: 10.1245/s10434-012-2708-5. Epub 2012 Oct 26. PubMed PMID: 23099729.

82: Mayr R, May M, Fritsche HM. Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012;62:662-70. Eur Urol. 2013 Jan;63(1):e10. doi: 10.1016/j.eururo.2012.09.044. Epub 2012 Sep 27. PubMed PMID: 23079054.

83: Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol. 2013 Apr;63(4):739-44. doi: 10.1016/j.eururo.2012.09.053. Epub 2012 Sep 28. PubMed PMID: 23079053.

84: Fritsche HM, Aziz A, Eder F, Otto W, Denzinger S, Wieland WF, May M, Hofstädter F, Hartmann A, Burger M. Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens. Virchows Arch. 2012 Dec;461(6):655-61. doi: 10.1007/s00428-012-1328-6. Epub 2012 Oct 9. PubMed PMID: 23052374.

85: Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S. Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer. BMC Cancer. 2012 Oct 8;12:459. doi: 10.1186/1471-2407-12-459. PubMed PMID: 23043286; PubMed Central PMCID: PMC3517507.

86: Fajkovic H, Cha EK, Xylinas E, Rink M, Pycha A, Seitz C, Bolenz C, Dunning A, Novara G, Trinh QD, Karakiewicz PI, Margulis V, Raman JD, Walton TJ, Baba S, Carballido J, Otto W, Montorsi F, Lotan Y, Kassouf W, Fritsche HM, Bensalah K, Zigeuner R, Scherr DS, Sonpavde G, Roupret M, Shariat SF. Disease-free survival as a surrogate for overall survival in upper tract urothelial carcinoma. World J Urol. 2013 Feb;31(1):5-11. doi: 10.1007/s00345-012-0939-5. Epub 2012 Sep 26. PubMed PMID: 23011256.

87: Rink M, Lee DJ, Kent M, Xylinas E, Fritsche HM, Babjuk M, Brisuda A, Hansen J, Green DA, Aziz A, Cha EK, Novara G, Chun FK, Lotan Y, Bastian PJ, Tilki D, Gontero P, Pycha A, Baniel J, Mano R, Ficarra V, Trinh QD, Tagawa ST, Karakiewicz PI, Scherr DS, Sjoberg DD, Shariat SF; Bladder Cancer Research Consortium. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy. BJU Int. 2013 Mar;111(3 Pt B):E30-6. doi: 10.1111/j.1464-410X.2012.11433.x. Epub 2012 Sep 3. PubMed PMID: 22938654.

88: Fritsche HM, Dötzer K. Improving the compliance of the recurrent stone-former. Arab J Urol. 2012 Sep;10(3):342-6. doi: 10.1016/j.aju.2012.07.003. Epub 2012 Aug 14. Review. PubMed PMID: 26558047; PubMed Central PMCID: PMC4442937.

89: Rink M, Shariat SF, Xylinas E, Fitzgerald JP, Hansen J, Green DA, Kamat AM, Novara G, Daneshmand S, Fradet Y, Tagawa ST, Bastian PJ, Kassouf W, Trinh QD, Karakiewicz PI, Fritsche HM, Tilki D, Chun FK, Volkmer BG, Babjuk M, Merseburger AS, Scherr DS, Lotan Y, Svatek RS. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol. 2012 Dec;30(6):807-14. doi: 10.1007/s00345-012-0910-5. Epub 2012 Jul 26. PubMed PMID: 22832587.

90: Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy. BJU Int. 2013 Jan;111(1):74-84. doi: 10.1111/j.1464-410X.2012.11356.x. Epub 2012 Jul 19. PubMed PMID: 22809039.

91: Shariat SF, Rink M, Ehdaie B, Xylinas E, Babjuk M, Merseburger AS, Svatek RS, Cha EK, Tagawa ST, Fajkovic H, Novara G, Karakiewicz PI, Trinh QD, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Chun FK, Sonpavde G, Joual A, Scherr DS, Gonen M. Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. Eur Urol. 2013 Feb;63(2):371-8. doi: 10.1016/j.eururo.2012.06.008. Epub 2012 Jun 16. PubMed PMID: 22727174.

92: Chromecki TF, Cha EK, Fajkovic H, Rink M, Ehdaie B, Svatek RS, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Daneshmand S, Kassouf W, Durand M, Novara G, Fritsche HM, Burger M, Izawa JI, Brisuda A, Babjuk M, Pummer K, Shariat SF. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy. BJU Int. 2013 Feb;111(2):249-55. doi: 10.1111/j.1464-410X.2012.11322.x. Epub 2012 Jun 21. PubMed PMID: 22727036.

93: Iblher N, Fritsche HM, Katzenwadel A, Penna V, Eisenhardt SU, Stark GB, Lampert F. Refinements in reconstruction of penile skin loss using intra-operative prostaglandin injections, postoperative tadalafil application and negative pressure dressings. J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1377-83. doi: 10.1016/j.bjps.2012.04.020. Epub 2012 May 24. PubMed PMID: 22633389.

94: Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2014 Jan;65(1):210-7. doi: 10.1016/j.eururo.2012.04.052. Epub 2012 May 4. PubMed PMID: 22579047.

95: Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol. 2012 Oct;62(4):662-70. doi: 10.1016/j.eururo.2012.03.057. Epub 2012 Apr 12. PubMed PMID: 22534059.

96: Rud O, Moersler J, Peter J, Waliszewski P, Gilfrich C, Häuser H, Burger M, Fritsche HM, Wieland WF, Ahmed AM, Brookman-May S, May M. Prospective evaluation of interobserver variability of the hydronephrosis index and the renal resistive index as sonographic examination methods for the evaluation of acute hydronephrosis. BJU Int. 2012 Oct;110(8 Pt B):E350-6. doi: 10.1111/j.1464-410X.2012.11087.x. Epub 2012 Apr 3. PubMed PMID: 22471558.

97: Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. Eur J Surg Oncol. 2012 Jul;38(7):637-42. doi: 10.1016/j.ejso.2012.02.187. Epub 2012 Mar 27. PubMed PMID: 22459902.

98: Rink M, Ehdaie B, Cha EK, Green DA, Karakiewicz PI, Babjuk M, Margulis V, Raman JD, Svatek RS, Fajkovic H, Lee RK, Novara G, Hansen J, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Fisch M, Scherr DS, Shariat SF; Bladder Cancer Research Consortium (BCRC); Upper Tract Urothelial Carcinoma Collaboration (UTUCC). Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. Eur Urol. 2012 Oct;62(4):677-84. Epub 2012 Feb 15. PubMed PMID: 22349570.

99: Roscigno M, Cha EK, Rink M, Seitz C, Novara G, Chromecki TF, Fritsche HM, Matsumoto K, Walton TJ, Carballido J, Filippo Da Pozzo L, Bertini R, Ficarra V, Otto W, Karakiewicz PI, Pycha A, Fajkovic H, Naspro R, Scherr DS, Montorsi F, Shariat SF. International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis. BJU Int. 2012 Sep;110(5):674-81. doi: 10.1111/j.1464-410X.2012.10930.x. Epub 2012 Feb 20. PubMed PMID: 22348322.

100: May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. J Urol. 2012 Apr;187(4):1210-4. doi: 10.1016/j.juro.2011.11.104. Epub 2012 Feb 14. PubMed PMID: 22335861.

101: Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM. Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder. BJU Int. 2012 Sep;110(6 Pt B):E222-7. doi: 10.1111/j.1464-410X.2012.10938.x. Epub 2012 Feb 7. PubMed PMID: 22314129.

102: Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021. Epub 2012 Jan 23. PubMed PMID: 22284969.

103: Kendoff D, Perka C, Fritsche HM, Gehrke T, Hube R. Oral thromboprophylaxis following total hip or knee replacement: review and multicentre experience with dabigatran etexilate. Open Orthop J. 2011;5:395-9. doi: 10.2174/1874325001105010395. Epub 2011 Dec 30. PubMed PMID: 22276081; PubMed Central PMCID: PMC3263520.

104: Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16. PubMed PMID: 22177329.

105: Knoll T, Fritsche HM, Rassweiler J. [Medical and Economic Aspects of Extracorporeal Shock Wave Lithotripsy]. Aktuelle Urol. 2011 Nov;42(6):363-7. doi: 10.1055/s-0031-1283805. Epub 2011 Nov 16. Review. German. PubMed PMID: 22090371.

106: May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a. Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6. PubMed PMID: 22056404.

107: Shariat SF, Ehdaie B, Rink M, Cha EK, Svatek RS, Chromecki TF, Fajkovic H, Novara G, David SG, Daneshmand S, Fradet Y, Lotan Y, Sagalowsky AI, Clozel T, Bastian PJ, Kassouf W, Fritsche HM, Burger M, Izawa JI, Tilki D, Abdollah F, Chun FK, Sonpavde G, Karakiewicz PI, Scherr DS, Gonen M. Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. Eur Urol. 2012 Feb;61(2):237-42. doi: 10.1016/j.eururo.2011.10.011. Epub 2011 Oct 21. PubMed PMID: 22033174.

108: Chromecki TF, Mauermann J, Cha EK, Svatek RS, Fajkovic H, Karakiewicz PI, Lotan Y, Tilki D, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Novara G, Fritsche HM, Ficarra V, Stief CG, Dinney CP, Skinner E, Pummer K, Fradet Y, Shariat SF. Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. World J Urol. 2012 Dec;30(6):753-9. doi: 10.1007/s00345-011-0772-2. Epub 2011 Oct 19. PubMed PMID: 22009117.

109: May M, Stief C, Brookman-May S, Otto W, Gilfrich C, Roigas J, Zacharias M, Wieland WF, Fritsche HM, Hofstädter F, Burger M. Gender-dependent cancer-specific survival following radical cystectomy. World J Urol. 2012 Oct;30(5):707-13. doi: 10.1007/s00345-011-0773-1. Epub 2011 Oct 9. PubMed PMID: 21984471.

110: Keck B, Lotter G, Wieland WF, Wullich B, Uder M, Engehausen DG, Fritsche HM. Sonographic diagnosis of a posttraumatic arteriocavernosal fistula resulting in high-flow priapism. J Clin Ultrasound. 2012 Jan;40(1):60-2. doi: 10.1002/jcu.20881. Epub 2011 Sep 27. PubMed PMID: 21953380.

111: Otto W, Burger M, Fritsche HM, Rössler W, Wieland WF, Denzinger S. The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosis. Future Oncol. 2011 Sep;7(9):1057-66. doi: 10.2217/fon.11.91. Review. PubMed PMID: 21919693.

112: Martinez-Salamanca JI, Shariat SF, Rodriguez JC, Chromecki TF, Ficarra V, Fritsche HM, Kassouf W, Matsumoto K, Cabello LO, Seitz C, Tritschler S, Walton TJ, Zattoni F, Novara G. Prognostic role of ECOG performance status in patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2012 Apr;109(8):1155-61. doi: 10.1111/j.1464-410X.2011.10479.x. Epub 2011 Aug 24. PubMed PMID: 21883847.

113: Nuhn P, May M, Sun M, Fritsche HM, Brookman-May S, Buchner A, Bolenz C, Moritz R, Herrmann E, Burger M, Tilki D, Trojan L, Perrotte P, Haferkamp A, Hohenfellner M, Wieland WF, Müller SC, Karakiewicz PI, Bastian PJ. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Eur Urol. 2012 Jan;61(1):58-64. doi: 10.1016/j.eururo.2011.07.066. Epub 2011 Aug 9. PubMed PMID: 21840642.

114: Fritsche HM, Otto W, Eder F, Hofstädter F, Denzinger S, Chaussy CG, Stief C, Wieland WF, Burger M. Water-jet-aided transurethral dissection of urothelial carcinoma: a prospective clinical study. J Endourol. 2011 Oct;25(10):1599-603. doi: 10.1089/end.2011.0042. Epub 2011 Aug 4. PubMed PMID: 21815824.

115: May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Fritsche HM. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. BJU Int. 2011 Oct;108(8 Pt 2):E278-83. doi: 10.1111/j.1464-410X.2011.10189.x. Epub 2011 Jun 23. PubMed PMID: 21699644.

116: Nuhn P, Bastian PJ, Novara G, Svatek RS, Karakiewicz PI, Skinner E, Fradet Y, Izawa JI, Kassouf W, Montorsi F, Müller SC, Fritsche HM, Sonpavde G, Tilki D, Isbarn H, Ficarra V, Dinney CP, Shariat SF. Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery. Urol Int. 2011;87(1):42-8. doi: 10.1159/000325463. Epub 2011 Jun 9. PubMed PMID: 21659717.

117: Burger M, Shariat SF, Fritsche HM, Martinez-Salamanca JI, Matsumoto K, Chromecki TF, Ficarra V, Kassouf W, Seitz C, Pycha A, Tritschler S, Walton TJ, Novara G. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study. World J Urol. 2011 Aug;29(4):465-72. doi: 10.1007/s00345-011-0705-0. Epub 2011 Jun 1. PubMed PMID: 21630120.

118: Ganzer R, Brandtner A, Wieland WF, Fritsche HM. Prospective blinded comparison of real-time sonoelastography targeted versus randomised biopsy of the prostate in the primary and re-biopsy setting. World J Urol. 2012 Apr;30(2):219-23. doi: 10.1007/s00345-011-0679-y. Epub 2011 Apr 26. PubMed PMID: 21519851.

119: Matsumoto K, Novara G, Gupta A, Margulis V, Walton TJ, Roscigno M, Ng C, Kikuchi E, Zigeuner R, Kassouf W, Fritsche HM, Ficarra V, Martignoni G, Tritschler S, Rodriguez JC, Seitz C, Weizer A, Remzi M, Raman JD, Bolenz C, Bensalah K, Koppie TM, Karakiewicz PI, Wood CG, Montorsi F, Iwamura M, Shariat SF. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study. BJU Int. 2011 Oct;108(8 Pt 2):E304-9. doi: 10.1111/j.1464-410X.2011.10188.x. Epub 2011 Apr 20. PubMed PMID: 21507184.

120: Chromecki TF, Ehdaie B, Novara G, Pummer K, Zigeuner R, Seitz C, Pycha A, Lee RK, Cha EK, Karakiewicz PI, Ng C, Raman JD, Chun FK, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Bastian PJ, Martínez-Salamanca JI, Scherr DS, Shariat SF. Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy. World J Urol. 2011 Aug;29(4):473-80. doi: 10.1007/s00345-011-0677-0. Epub 2011 Apr 17. PubMed PMID: 21499902.

121: Kassouf W, Svatek RS, Shariat SF, Novara G, Lerner SP, Fradet Y, Bastian PJ, Aprikian A, Karakiewicz PI, Fritsche HM, Dinney CP, Tilki D, Kamat AM, Izawa JI, Ficarra V, Lotan Y, Sagalowsky AI, Schoenberg MP, Skinner EC. Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder. Urol Oncol. 2013 May;31(4):480-6. doi: 10.1016/j.urolonc.2011.02.011. Epub 2011 Apr 8. PubMed PMID: 21478035.

122: May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Fritsche HM. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scand J Urol Nephrol. 2011 Sep;45(4):251-7. doi: 10.3109/00365599.2011.562235. Epub 2011 Mar 10. PubMed PMID: 21388337.

123: May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Bretschneider-Ehrenberg P, Müller O, Zacharias M, Gunia S, Bastian PJ. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]. Urologe A. 2011 Jun;50(6):706-13. doi: 10.1007/s00120-011-2506-x. German. PubMed PMID: 21340594.

124: May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Müller O, Bretschneider-Ehrenberg P, Zacharias M, Gunia S, Bastian PJ. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. Urologe A. 2011 Jul;50(7):821-9. doi: 10.1007/s00120-011-2507-9. German. PubMed PMID: 21340593.

125: Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Scherr DS, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T3N0 bladder cancer after radical cystectomy. J Urol. 2011 Apr;185(4):1216-21. doi: 10.1016/j.juro.2010.11.082. Epub 2011 Feb 22. PubMed PMID: 21334687.

126: May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, Roigas J, Zacharias M, Gunia S, Wieland WF, Hohenfellner M, Michel MS, Haferkamp A, Müller SC, Stief CG, Bastian PJ. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. Eur Urol. 2011 May;59(5):712-8. doi: 10.1016/j.eururo.2011.01.030. Epub 2011 Jan 28. PubMed PMID: 21296488.

127: Otto W, Shariat SF, Fritsche HM, Gupta A, Matsumoto K, Kassouf W, Martignoni G, Walton TJ, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Burger M, Karakiewicz PI, Ficarra V, Novara G. Concomitant carcinoma in situ as an independent prognostic parameter for recurrence and survival in upper tract urothelial carcinoma: a multicenter analysis of 772 patients. World J Urol. 2011 Aug;29(4):487-94. doi: 10.1007/s00345-011-0645-8. Epub 2011 Jan 20. PubMed PMID: 21249372.

128: Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder. Pathol Res Pract. 2011 Mar 15;207(3):161-3. doi: 10.1016/j.prp.2010.12.006. Epub 2011 Jan 17. PubMed PMID: 21247708.

129: May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Bastian PJ. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Ann Surg Oncol. 2011 Jul;18(7):2018-25. doi: 10.1245/s10434-010-1538-6. Epub 2011 Jan 19. PubMed PMID: 21246405.

130: Svatek RS, Shariat SF, Novara G, Skinner EC, Fradet Y, Bastian PJ, Kamat AM, Kassouf W, Karakiewicz PI, Fritsche HM, Izawa JI, Tilki D, Ficarra V, Volkmer BG, Isbarn H, Dinney CP. Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort. BJU Int. 2011 Mar;107(6):898-904. doi: 10.1111/j.1464-410X.2010.09628.x. Epub 2011 Jan 18. PubMed PMID: 21244604.

131: Eriksson BI, Dahl OE, Huo MH, Kurth AA, Hantel S, Hermansson K, Schnee JM, Friedman RJ; RE-NOVATE II Study Group. Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial. Thromb Haemost. 2011 Apr;105(4):721-9. doi: 10.1160/TH10-10-0679. Epub 2011 Jan 12. PubMed PMID: 21225098.

132: Sonpavde G, Khan MM, Lerner SP, Svatek RS, Novara G, Karakiewicz PI, Skinner E, Tilki D, Kassouf W, Fradet Y, Dinney CP, Fritsche HM, Izawa JI, Bastian PJ, Ficarra V, Schoenberg M, Sagalowsky AI, Lotan Y, Shariat SF. Disease-free survival at 2 or 3 years correlates with 5-year overall survival of patients undergoing radical cystectomy for muscle invasive bladder cancer. J Urol. 2011 Feb;185(2):456-61. doi: 10.1016/j.juro.2010.09.110. Epub 2010 Dec 17. PubMed PMID: 21167527.

133: Sonpavde G, Khan MM, Svatek RS, Lee R, Novara G, Tilki D, Lerner SP, Amiel GE, Skinner E, Karakiewicz PI, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Ficarra V, Dinney CP, Lotan Y, Fradet Y, Shariat SF. Prognostic risk stratification of pathological stage T2N0 bladder cancer after radical cystectomy. BJU Int. 2011 Sep;108(5):687-92. doi: 10.1111/j.1464-410X.2010.09902.x. Epub 2010 Nov 19. PubMed PMID: 21087453.

134: Walton TJ, Novara G, Matsumoto K, Kassouf W, Fritsche HM, Artibani W, Bastian PJ, Martínez-Salamanca JI, Seitz C, Thomas SA, Ficarra V, Burger M, Tritschler S, Karakiewicz PI, Shariat SF. Oncological outcomes after laparoscopic and open radical nephroureterectomy: results from an international cohort. BJU Int. 2011 Aug;108(3):406-12. doi: 10.1111/j.1464-410X.2010.09826.x. Epub 2010 Nov 15. PubMed PMID: 21078048.

135: Kreiner B, Denzinger S, Ganzer R, Fritsche HM, Burger M, Wieland WF, Otto W. Neuroendocrine carcinoma of the seminal vesicles presenting with Lambert Eaton syndrome: a case report. J Med Case Rep. 2010 Oct 12;4:320. doi: 10.1186/1752-1947-4-320. PubMed PMID: 20939874; PubMed Central PMCID: PMC2964736.

136: Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma. Urol Oncol. 2012 Sep;30(5):666-72. doi: 10.1016/j.urolonc.2010.07.010. Epub 2010 Oct 8. PubMed PMID: 20933445.

137: May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Gilfrich C, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Gunia S, Bastian PJ. [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]. Urologe A. 2010 Dec;49(12):1508-15. doi: 10.1007/s00120-010-2424-3. German. PubMed PMID: 20922515.

138: Shariat SF, Favaretto RL, Gupta A, Fritsche HM, Matsumoto K, Kassouf W, Walton TJ, Tritschler S, Baba S, Matsushita K, Bastian PJ, Martínez-Salamanca JI, Seitz C, Pycha A, Otto W, Karakiewicz PI, Ficarra V, Novara G. Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World J Urol. 2011 Aug;29(4):481-6. doi: 10.1007/s00345-010-0594-7. Epub 2010 Oct 1. PubMed PMID: 20886219.

139: Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A. The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer. 2011 Jul 15;129(2):346-54. doi: 10.1002/ijc.25700. Epub 2010 Dec 1. PubMed PMID: 20878954.

140: Fritsche HM, Burger M, Dietmaier W, Denzinger S, Bach E, Otto W, Doblinger M, Schwarz S, Buchner H, Hartmann A. Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder. Am J Clin Pathol. 2010 Oct;134(4):597-603. doi: 10.1309/AJCPKKWBDSAOZ4RW. PubMed PMID: 20855641.

141: Seitz C, Gupta A, Shariat SF, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Otto W, Tritschler S, Bastian PJ, Carballido J, Ficarra V, Karakiewicz PI, Artibani W, Mazzoleni G, Novara G. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J Urol. 2010 Nov;184(5):1895-900. doi: 10.1016/j.juro.2010.06.106. Epub 2010 Sep 17. PubMed PMID: 20846680.

142: Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int. 2011 Feb;107(3):404-8. doi: 10.1111/j.1464-410X.2010.09515.x. Epub 2010 Aug 12. Review. PubMed PMID: 20707791.

143: Otto W, Fritsche HM, Dirmeyer M, Burger M, Straub M, Rössler W, Wieland WF, Denzinger S. [Analysis of Clinical, Histopathological and Follow-Up Data on Transurethral Resections of the Bladder Performed during One Year at a University Centre]. Aktuelle Urol. 2010 Sep;41(5):316-9. doi: 10.1055/s-0030-1247481. Epub 2010 Jul 28. German. PubMed PMID: 20669097.

144: Svatek RS, Shariat SF, Lasky RE, Skinner EC, Novara G, Lerner SP, Fradet Y, Bastian PJ, Kassouf W, Karakiewicz PI, Fritsche HM, Müller SC, Izawa JI, Ficarra V, Sagalowsky AI, Schoenberg MP, Siefker-Radtke AO, Millikan RE, Dinney CP. The effectiveness of off-protocol adjuvant chemotherapy for patients with urothelial carcinoma of the urinary bladder. Clin Cancer Res. 2010 Sep 1;16(17):4461-7. doi: 10.1158/1078-0432.CCR-10-0457. Epub 2010 Jul 22. PubMed PMID: 20651056.

145: Tilki D, Svatek RS, Novara G, Seitz M, Godoy G, Karakiewicz PI, Kassouf W, Fradet Y, Fritsche HM, Sonpavde G, Izawa JI, Ficarra V, Lerner SP, Schoenberg M, Stief CG, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Reich O, Shariat SF. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol. 2010 Sep;184(3):888-94. doi: 10.1016/j.juro.2010.04.081. Erratum in: J Urol. 2010 Nov;184(5):2218. PubMed PMID: 20643448.

146: Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, Lotan Y, Isbarn H, Capitanio U, Bastian PJ, Kassouf W, Fritsche HM, Izawa JI, Tilki D, Dinney CP, Lerner SP, Schoenberg M, Volkmer BG, Sagalowsky AI, Shariat SF. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010 Jun;183(6):2165-70. doi: 10.1016/j.juro.2010.02.021. PubMed PMID: 20399473.

147: Tilki D, Reich O, Svatek RS, Karakiewicz PI, Kassouf W, Novara G, Ficarra V, Chade DC, Fritsche HM, Gerwens N, Izawa JI, Lerner SP, Schoenberg M, Stief CG, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Characteristics and outcomes of patients with clinical carcinoma in situ only treated with radical cystectomy: an international study of 243 patients. J Urol. 2010 May;183(5):1757-63. doi: 10.1016/j.juro.2010.01.025. Epub 2010 Mar 17. PubMed PMID: 20299059.

148: Shariat SF, Svatek RS, Tilki D, Skinner E, Karakiewicz PI, Capitanio U, Bastian PJ, Volkmer BG, Kassouf W, Novara G, Fritsche HM, Izawa JI, Ficarra V, Lerner SP, Sagalowsky AI, Schoenberg MP, Kamat AM, Dinney CP, Lotan Y, Marberger MJ, Fradet Y. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU Int. 2010 May;105(10):1402-12. doi: 10.1111/j.1464-410X.2010.09217.x. Epub 2010 Feb 2. PubMed PMID: 20132195.

149: Novara G, Matsumoto K, Kassouf W, Walton TJ, Fritsche HM, Bastian PJ, Martínez-Salamanca JI, Seitz C, Lemberger RJ, Burger M, El-Hakim A, Baba S, Martignoni G, Gupta A, Karakiewicz PI, Ficarra V, Shariat SF. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010 Jun;57(6):1064-71. doi: 10.1016/j.eururo.2009.12.029. Epub 2010 Jan 6. PubMed PMID: 20071073.

150: Bolenz C, Herrmann E, Bastian PJ, Michel MS, Wülfing C, Tiemann A, Buchner A, Stief CG, Fritsche HM, Burger M, Wieland WF, Höfner T, Haferkamp A, Hohenfellner M, Müller SC, Ströbel P, Trojan L. Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. BJU Int. 2010 Aug;106(4):493-9. doi: 10.1111/j.1464-410X.2009.09166.x. Epub 2010 Jan 8. PubMed PMID: 20067452.

151: Zaak D, Burger M, Otto W, Bastian PJ, Denzinger S, Stief CG, Buchner H, Hartmann A, Wieland WF, Shariat SF, Fritsche HM. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms. BJU Int. 2010 Aug;106(3):342-8. doi: 10.1111/j.1464-410X.2009.09138.x. Epub 2009 Dec 11. PubMed PMID: 20002664.

152: Tilki D, Svatek RS, Karakiewicz PI, Isbarn H, Reich O, Kassouf W, Fradet Y, Novara G, Fritsche HM, Bastian PJ, Izawa JI, Stief CG, Ficarra V, Lerner SP, Schoenberg M, Dinney CP, Skinner E, Lotan Y, Sagalowsky AI, Shariat SF. Characteristics and outcomes of patients with pT4 urothelial carcinoma at radical cystectomy: a retrospective international study of 583 patients. J Urol. 2010 Jan;183(1):87-93. doi: 10.1016/j.juro.2009.08.145. PubMed PMID: 19942232.

153: Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol. 2010 Feb;57(2):300-9. doi: 10.1016/j.eururo.2009.09.024. Epub 2009 Sep 12. Erratum in: Eur Urol. 2015 Jul;68(1):171. PubMed PMID: 19766384.

154: Seitz C, Fritsche HM, Siebert T, Martini T, Wieland WF, Pycha A, Burger M. Novel electromagnetic lithotriptor for upper tract stones with and without a ureteral stent. J Urol. 2009 Oct;182(4):1424-9. doi: 10.1016/j.juro.2009.06.045. Epub 2009 Aug 15. PubMed PMID: 19683296.

155: Fritsche HM, Ganzer R, Schlaier J, Wieland WF, Brawanski A, Lange M. Acute urinary retention in two patients after subthalamic nucleus deep brain stimulation (STN-DBS) for the treatment of advanced Parkinson's disease. Mov Disord. 2009 Jul 30;24(10):1553-4. doi: 10.1002/mds.22631. PubMed PMID: 19441136.

156: Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W. Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder. Scand J Urol Nephrol. 2009;43(4):282-7. doi: 10.1080/00365590902854354. PubMed PMID: 19382004.

157: Ganzer R, Blana A, Stolzenburg JU, Rabenalt R, Fritsche HM, Wieland WF, Denzinger S. Nerve quantification and computerized planimetry to evaluate periprostatic nerve distribution-does size matter? Urology. 2009 Aug;74(2):398-403. doi: 10.1016/j.urology.2008.12.076. Epub 2009 Apr 18. PubMed PMID: 19375785.

158: Otto W, Burger M, Fritsche HM, Blana A, Roessler W, Knuechel R, Wieland WF, Denzinger S. Photodynamic diagnosis for superficial bladder cancer: do all risk-groups profit equally from oncological and economic long-term results? Clin Med Oncol. 2009 Apr 30;3:53-8. PubMed PMID: 20689609; PubMed Central PMCID: PMC2872595.

159: Fritsche HM, Burger M. Management of early-invasive high-grade transitional cell carcinoma of the bladder. Minerva Urol Nefrol. 2008 Dec;60(4):265-71. Review. PubMed PMID: 18923363.

160: Fritsche HM, Burger M, Denzinger S, Legal W, Goebell PJ, Hartmann A. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases. J Urol. 2008 Nov;180(5):1923-7. doi: 10.1016/j.juro.2008.07.035. Epub 2008 Sep 17. Review. PubMed PMID: 18801525.

161: Keck B, Stöhr R, Goebell PJ, Fritsche HM, Wullich B, Hartmann A. [Plasmacytoid carcinoma. Five case reports of a rare variant of urothelial carcinoma]. Pathologe. 2008 Sep;29(5):379-82. doi: 10.1007/s00292-008-1017-z. German. PubMed PMID: 18600326.

164: Fritsche HM, Burger M, Ganzer R, Otto W, Denzinger S, Wieland WF. [Impact of comorbidity on perioperative mortality after radical cystectomy]. Aktuelle Urol. 2008 May;39(3):225-8. doi: 10.1055/s-2008-1038161. German. PubMed PMID: 18478497.

165: Denzinger S, Burger M, Fritsche HM, Ganzer R, Blana A, Wieland WF, Otto W. [Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?]. Aktuelle Urol. 2008 Jan;39(1):58-61; discussion 62-3. doi: 10.1055/s-2007-980147. German. PubMed PMID: 18228189.

166: Denzinger S, Otto W, Fritsche HM, Roessler W, Wieland WF, Hartmann A, Burger M. Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients. Int J Urol. 2007 Nov;14(11):995-9; discussion 999. PubMed PMID: 17956523.

167: Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach? Eur Urol. 2008 Jan;53(1):146-52. Epub 2007 Jun 27. PubMed PMID: 17624657.

Weitere Publikationen

Buchherausgabe

Liedl B: Urogenitale Tumoren. Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual des Tumorzentrums München
Zuckschwerdt Verlag, München, 2003
ISBN 3-88603-820-3

Petros P, McCredie J, Skilling PM, Witczak M: Ratgeber Inkontinenz und Beckenbodenbeschwerden. Springerverlag Heidelberg, 2016, in Druck

Originalarbeiten

Probe-based confocal laser endomicroscopy (pCLE): a preclinical investigation of the male genital tract.
Trottmann M, Sroka R, Stepp H, Liedl B, Becker AJ, Stief CG, Kölle S. Lasers Med Sci 2016;31:57-65

Female urethral obstruction and bladder neck stenosis – fact or myth – how to proceed
Gunnemann A, Liedl B, Palma PC, Yoshimura Y, Muctar S.
Aktuelle Urol 2015; 46:382-387

Katheter-assoziierte Harnwegsinfektionen
Liedl B
Urologe A 2015; 54:1301-1308, quiz 1308-1310

Effects of posture and squatting on the dynamics of micturition
Bush MB, Liedl B, Wagenlehner F, Yassouridis A, Petros P
Int Urogynecol J 2015;26:779-780

A finite element model validates an external mechanism for opening the urethral tube prior to micturition in the female
Bush MB, Liedl B, Wagenlehner F, Petros P
World J Urol 2015;33:1151-1157

Probe-based confocal laser endomicrosopgy (pCLE) a new imaging technique for in situ localization of spermatozoa
Trottmann A, Stepp H, Sroka R, Heide M, Liedl B, Reese S, Becker AJ, Stief CG, Kölle S
J Biophotonics 2015; 8:415-421


Use of Martius flaps in complex female urethral surgery and the tethered vagina syndrome.
Petros P, Gunnemann A, Liedl B
Cent European J Urol 2014;67:208-209

A review and critical analysis of historical operations for urinary stress incontinence. Part 1: vaginal surgery
B. Liedl, F. Wagenlehner, P. Petros
Pelviperineology 2014; 33 (2) 35-40
A review and critical analysis of historical operations for cure of urinary stress incontinence. Part 2- abdominal sling operations
B. Liedl, P. Petros, F. Wagenlehner
Pelviperineology 2014;33 (3): 68-73

Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours
Liedl B, Khoder WY, Ruhdorfer-Metz B, Stief CG, Waidelich R
Int Urogynecol J 2014;25:953-960

Comment on Nager: the urethra is a reliable witness: simplifying the diagnosis of stress urinary incontinence
Wagenlehner, FM, Liedl B, Bschleipfer T, Petros P
Int Urogynecol J 2013;24:1413-1414

Elevate anterior/apical:12-months data showing safety and efficacy in surgical treatment of pelvic organ prolapse
Stanford EJ, Moore RD, Roovers JP, Courieu C, Lukban JC, Bataller E, Liedl B, Sutherland SE
Female Pelvic Med Reconstr Surg 2013;19:79-83

A comprehensive anatomical view on pelvic floor disturbances
Wagenlehner FM, Bschleipfer T, Weidner W, Liedl B, Gunnemann A
Neurourol Urodyn 2010;84:1-9

Surgical reconstruction of pelvic floor descent: anatomical and functional aspects
Wagenlehner FM, Bschleipfer T, Liedl B, Gunnemann A, Petros P, Weidner W
Urol Int 2010; 84:1-9

Male and female urinary incontinence from the viewpoint of the pelvic floor surgeon
Liedl B
Urologe A 2010;49:289-303

Functional aspects of pelvic floor surgery
Wagenlehner FM, Gunnemann A, Liedl B, Weidner W
Aktuelle Urol. 2009;40:345-350

Upper trasverse scrotal approach for muscle- and nerve sparing urethral stricture repair
Seitz M, Liedl B, Becker A, Gratzke C, Reich O, Stief C
World J Urol 2009;27:557-572


Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients
Reich O, Gratzke C, .... Liedl B, ...
J Urol 2008;180:246-249

Treatment of urinary incontinence in the elderly women
Liedl B
MMW Fortschr Med 2005;147:48-50

Bladder catheterization in nursing care. An unresolved problem! Initiative to build a guideline
Liedl B, Gleissner J, Göckel-Beining B, Knopf HJ, Kopp I, Lenk S, Naber K, Tschuschke C, Piechota HJ
Urologe A 2005;44:1369-1373

Management and outcome of bilateral testicular germ cell tumors: Twenty-five year experience in Munich
Hentrich M, Weber N, Bergsdorf T, Liedl B, Hartenstein R, Gerl A
Acta Oncol 2005;44:529-536

The development of concepts of female (in)contincence. Pathophysiology, diagnostics and surgical therapy
Liedl B, Schorsch I, Stief C
Urologe A 2005;44:803-820

Management of urinary incontinence in the aging man
Staehler M, Liedl B
MMW Fortschr Med 2005;147:29-32

Urinary stress incontinence in women
Liedl B
Aktuelle Urol 2004;35:485-490

Durability of probes for interstitial laser coagulation: impact of power setting and probe design
Reich O, Michel MS, Schneede P, Liedl B, Hofstetter A
J Endourol 2004;18:299-302

Fluorescence cytology of the urinary bladder
Tauber S, Schneede P, Liedl B, Liesmann F, Zaak D, Hofstetter A.
Urology 2003;61:1067-1071

European Association of Urology guidelines on urinary and male genital tract infections
Schneede P, Hofstetter AG, Naber KG, ... Liedl B, ...
Urologe A 2003;42:104-112

Urogenital infections in the elderly
Weidner W, Hochreiter W, Liedl B et al.
Urologe A 2002;41:328-332

Simultaneous microsurgical spermatic vein ligation and sclerotherapy. A combined procedure for the treatment of recurrent or persistent varicocele
Corvin S, Liedl B, Adam C, et al.
Eur Urol 2001;40:350-353

Fluorescence cytology of the urinary bladder
Tauber S, Liedl B, Schneede P et al.
Urologe A 2001;40:217-221

Catheter-associated urinary tract infections
Liedl B
Curr Opin Urol 2001;11:75-79

The therapy of testicular tumors 2 decades after the intraduction of cisplatin
Gerl A, Sauer H, Liedl B, Hiddemann W.
Dtsch Med Wochenschr 2000;125:327-334

Large de novo renal cell carcinoma in a 10-year-old transplanted kidney: successful organ-preserving therapy
Siebels M, Theodorakis J, Liedl B, Schneede P, Hofstetter A.
Transplantation 2000; 69:677-679

Sex-adjusting surgery in transsexualism
Liedl B
MMW Fortschr Med 1999;141:41-45

Laserlithotripsy of ureteral calculi
Schmeller N, Ehsan A, Kriegmair M, Muschter R, Liedl B, Hofstetter A
Urologe A 1994;33:308-311

Renal cell carcinoma – diagnosis, differential diagnosis and prognosis
Liedl B, Liedl T, Hofstetter AG
Fortschr Med 1992;110:431-434

NMR tomography of vena cava thrombi: clinical significance in the differental diagnosis and therapy
Liedl B, Schmidt H, Mayr B, Beer M, Staehler G, Jocham D
Helv Chir Acta 1990;57:447-450

Schmeller N, Kriegmair M, Liedl B, et al.
Urologe A 1990;29:309-312

The clinical value of NMR tomography for retroperitoneal diagnosis
Beer M, Schmidt H, Liedl B, Mayr W
Helv Chir Acta 1989;56:271-374

Long-term experiences following extracorporeal shockwave lithotripsy in patients with urinary calculi
Jocham D, Liedl B, Lunz C, Schuster C, Chaussy C
Urologe A 1989;28:134-137

Prevalence and incidence of arterial hypertension in patients with kidney calculi treated by extracorporeal shock wave lithotripsy
Liedl B, Jocham D, Lunz C, Schuster C, Chaussy C
Urologe A 1989;28:130-133

The current status and place of open surgery in treating urolithiasis
Fabricius PB, Jocham D, Liedl B, Fornara P, Gotsev G
Khirurgiia (Sofiia) 1989;42:1-7

Causes, prevention and therapy of complications of lymphadenectomy following tumor nephrectomy
Fabricius PG, Liedl B, Staehler G, Kokesch-Häuser S, Schmiedt E.
Urologe A 1988;27:221-224

Kidney cancer with invasion of the vena cava: classification, surgical strategy and results of treatment
Staehler G, Liedl B, Kreuzer E, Sturm W, Schmiedt E.
Urologe A 1987;26:46-50

Modern strategy of cystine calculus treatment
Kersting H, Chaussy C, Jocham D, Liedl B
Helv Chir Acta 1985;52:485-488
Expansion of extracorporeal shock wave lithotripsy by auxiliary methods
Schüller J, Chassy C, Jocham D, Brandl H, Liedl B, Schmiedt E
Urologe A 1984;23:317-323

Extracorporal shock-wave lithotripsy (ESWL) for treatment of urolithiasis
Chaussy C, Schüller J, Schmiedt E, Brandl H, Jocham D, Liedl B
Urology 1984;23:59-66

Buchbeiträge

Drainage des Harntrakts
Liedl B.
In Jocham, Miller. Praxis der Urologie, Band 1., 3. Auflage, Thieme, Stuttgart 2016, S. 335-356

Urologische Wundbehandlung und Verband
Liedl B.
In Jocham, Miller. Praxis der Urologie, Band 1, 3. Auflage, Thieme, Stuttgart 2016. S. 306-326

Komplizierte Harnwegsinfektionen
Liedl B
In: Schmelz, Sparwasser, Weidner (HRG). Facharztwissen Urologie. 3. Auflage Springer Berlin-Heidelberg 2014, S. 47-50

Pathophysiology of Urinary Incontinence and Pelvic Floor dysfunctions in Female
Liedl B, Riegel M, Markovsky O
In Chung E: Urinary Incontinence. Causes, Epidemiology and Treatment
Nova Biomedical New York 2013, S. 1-18

The role of Altered Connective Tissue in the Causation of Pelvic Floor Symptoms
Liedl B, Markovsky O, Wagenlehner F, Gunnemann A
In Ammar Alhasso und Ashani Fernando: Urinary Incontinence. Intech, Rijeka, 2012
S. 1 - 20


Komplikationen der Inkontinenzchirurgie, Prolapschirurgie, Prothetik. Allgemeine Aspekte
Liedl B
In: Anheuser, Steffen. Risiken und Komplikationen in der Urologie, Thieme, Stuttgart, 2012, S. 196-198

Operative Ansätze beim fortgeschrittenden Nierenzellkarzinom
B. Liedl
In: M. Siebels, CG Stief: Neue Therapieansätze beim metastasierten Nierenzellkarzinom.
Unimed Verlag AG Bremen 2007. S.70-73

Lebensqualität nach Prostatakarzinomtherapie
Liedl B
In: A. Hofstetter (Hrg.) Prostatakarzinom. Fortschritte in Diagnostik und Therapie
Urban & Vogel München 2006, S. 108-125

Nachsorge nach Therapie des Prostatakarzinoms
Liedl B
In: A. Hofstetter (Hrg.) Prostatakarzinom. Fortschritte in Diagnostik und Therapie
Urban & Vogel München 2006, S. 126-129

Katheterassoziierte Harnwegsinfektionen
Liedl B
In: A. Hofstetter: Urogenitale Infektionen. Springer Berlin-Heidelberg-New York 1999. S. 241-264

Harnblasenkarzinom
Liedl B, Zaak D, Schwaibold H, Hungerhuber E, Zimmermann F, Treiber U, Weiss M.
In B. Liedl (Hrg) Urogenitale Tumoren, Manual des Tumorzentrums München. Zuckschwerdt-Verlag München 2003, S. 43 – 78

Hodentumoren
Gerl A, Barba M, Weiss M, Liedl B, Zimmermann F, Clemm C
In B. Liedl (Hrg) Urogenitale Tumoren, Manual des Tumorzentrums München. Zuckschwerdt-Verlag München 2003, S. 98-126

Gonadotoxizität von Chemo- und Strahlentherapie
Clemm Ch, Liedl B, Zimmermann F
In B. Liedl (Hrg) Urogenitale Tumoren, Manual des Tumorzentrums München. Zuckschwerdt-Verlag München 2003, S. 181-189

SCHNELLAUSWAHL

Kontakt

Die Klinik

Zentren/Praxen

Über uns

Hauptmenü